Benzinga - Tue, 13 Apr 2021 05:18:31 -0400
Benzinga - Mon, 12 Apr 2021 12:45:21 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
Benzinga - Tue, 30 Mar 2021 07:18:18 -0400
Benzinga - Tue, 30 Mar 2021 04:04:11 -0400
Benzinga - Mon, 29 Mar 2021 10:05:58 -0400
load more
Sector: Health Care.Industry: Biotechnology
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2020Est.ActualSurprise
EPS-0.240-0.260 -0.0200
REV3.820M1.877M-1.943M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PIRSPieris Pharmaceuticals-3.02%122.2M

Pieris Pharmaceuticals Company Questions & Answers

Q

How do I buy Pieris Pharmaceuticals (PIRS) stock?

A

You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pieris Pharmaceuticals's (PIRS) main competitors?

A

Other companies in Pieris Pharmaceuticals’s space includes: GlycoMimetics (NASDAQ:GLYC), PhaseBio Pharmaceuticals (NASDAQ:PHAS) and CollPlant Biotechnologies (NASDAQ:CLGN).

Q

What is the target price for Pieris Pharmaceuticals?

A

The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on 2020-03-13. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 159.07% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Pieris Pharmaceuticals (PIRS) stock ?

A

The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $1.93 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Pieris Pharmaceuticals (PIRS) dividend?

A

There are no upcoming dividends for Pieris Pharmaceuticals.

Q

When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?

A
Pieris Pharmaceuticals’s Q2 earnings are confirmed after-market from now on August 9, 2021.
Q

When is the upcoming split for PIRS?

A

There is no upcoming split for Pieris Pharmaceuticals.